Stock A086060 GENEBIOTECH CO. ,LTD
Add to a list
To use this feature you must be a member
Log inSign up

News GeneBioTech Co. ,Ltd

Equities

A086060

KR7086060001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 26/06/2024 BST 		5-day change 1st Jan Change
3,965 KRW +1.02% Intraday chart for GeneBioTech Co. ,Ltd -0.38% -9.06%
2023 GeneBioTech Co. ,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2018 GL Pharm Tech Corp. announced that it has received KRW 2 billion in funding from Daone Chemical Co., Ltd., Genebiotech Co., Ltd. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GeneBioTech Co. ,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
GL Pharm Tech Corp. announced that it has received KRW 2 billion in funding from Daone Chemical Co., Ltd., Genebiotech Co., Ltd.
CI
Hyundai-Tongyang Agrifood Private Equity Fund, fund of Yuanta Investment and two related parties acquired additional 4.47% stake in Genebiotech Co., Ltd..
CI
Gene Bio Tech Co., Ltd.'s Equity Buyback in the amount of KRW600 mm has expired
CI
Gene Bio Tech Co., Ltd.’s Equity Buyback Plan Extended till March 18, 2014
CI
Gene Bio Tech Co., Ltd.'s Equity Buyback Plan Extended till March 18, 2013
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A086060 Stock
  4. News GeneBioTech Co. ,Ltd